Table 2.
Demographic and Clinical Characteristics of SARS-CoV-2–Infected Symptomatic Patients With Mild, Moderate, and Severe Disease
| Characteristics | Control (n = 4) | Mild (n = 22) | Moderate (n = 36) | Severe (n = 8) |
|---|---|---|---|---|
| Age, y, mean ± SD | 47.75 ± 7.85 | 43.32 ± 18.38 | 40.81 ± 11.80 | 54.00 ± 12.38 |
| Men | 2 (50) | 13 (59) | 19 (53) | 5 (63) |
| Women | 2 (50) | 9 (41) | 17 (47) | 3 (37) |
| Time from onset, d, mean ± SD | NA | 4.45 ± 4.76 | 4.42 ± 2.81 | 4.25 ± 2.05 |
| No. of deaths | 0 | 0 | 0 | 0 |
| Fever (temperature ≥ 37.3℃) | 0 | 16 (73) | 33 (92) | 8 (100) |
| Malaise | 0 | 6 (27) | 13 (36) | 2 (25) |
| Cough | 0 | 7 (32) | 15 (42) | 2 (25) |
| Sputum | 0 | 5 (23) | 9 (25) | 3 (38) |
| Pharyngalgia | 0 | 3 (14) | 10 (28) | 1 (13) |
| Headache | 0 | 4 (18) | 3 (8) | 1 (13) |
| Myalgia | 0 | 2 (9) | 8 (22) | 2 (25) |
| Emesis | 0 | 0 | 1 (3) | 0 |
| Diarrhea | 0 | 0 | 6 (17) | 0 |
| Comorbidities | 0 | 6 (27) | 8 (22) | 4 (50) |
| Hypertension | 0 | 3 (14) | 3 (8) | 4 (50) |
| Diabetes | 0 | 3 (14) | 1 (3) | 0 |
| Cardiocerebrovascular disease | 0 | 0 | 0 | 2 (25) |
| Chronic lung disease | 0 | 0 | 1 (3) | 1 (13) |
| Chronic kidney disease | 0 | 0 | 1 (3) | 0 |
| Chronic liver disease | 0 | 0 | 0 | 1 (13) |
| Other | 0 | 2 (9) | 4 (11) | 0 |
Data are No. (%) except where indicated.
Abbreviation: NA, not applicable; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.